Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Adv ; 1(6)2015 Jul.
Article in English | MEDLINE | ID: mdl-26501130

ABSTRACT

This study introduces new methods of screening for and tuning chiral space and in so doing identifies a promising set of chiral ligands for asymmetric synthesis. The carbafructopyranosyl-1,2-diamine(s) and salens constructed therefrom are particularly compelling. It is shown that by removing the native anomeric effect in this ligand family, one can tune chiral ligand shape and improve chiral bias. This concept is demonstrated by a combination of (i) x-ray crystallographic structure determination, (ii) assessment of catalytic performance, and (iii) consideration of the anomeric effect and its underlying dipolar basis. The title ligands were identified by a new mini version of the in situ enzymatic screening (ISES) procedure through which catalyst-ligand combinations are screened in parallel, and information on relative rate and enantioselectivity is obtained in real time, without the need to quench reactions or draw aliquots. Mini-ISES brings the technique into the nanomole regime (200 to 350 nmol catalyst/20 µml organic volume) commensurate with emerging trends in reaction development/process chemistry. The best-performing ß-d-carbafructopyranosyl-1,2-diamine-derived salen ligand discovered here outperforms the best known organometallic and enzymatic catalysts for the hydrolytic kinetic resolution of 3-phenylpropylene oxide, one of several substrates examined for which the ligand is "matched." This ligand scaffold defines a new swath of chiral space, and anomeric effect tunability defines a new concept in shaping that chiral space. Both this ligand set and the anomeric shape-tuning concept are expected to find broad application, given the value of chiral 1,2-diamines and salens constructed from these in asymmetric catalysis.

2.
Chemistry ; 16(19): 5778-82, 2010 May 17.
Article in English | MEDLINE | ID: mdl-20391558

ABSTRACT

Site-directed spin labeling and EPR spectroscopy offer accurate, sensitive tools for the characterization of structure and function of macromolecules and their assemblies. A new rigid spin label, spirocyclohexyl nitroxide alpha-amino acid and its N-(9-fluorenylmethoxycarbonyl) derivative, have been synthesized, which exhibit slow enough spin-echo dephasing to permit accurate distance measurements by pulsed EPR spectroscopy at temperatures up to 125 K in 1:1 water/glycerol and at higher temperatures in matrices with higher glass transition temperatures. Distance measurements in the liquid nitrogen temperature range are less expensive than those that require liquid helium, which will greatly facilitate applications of pulsed EPR spectroscopy to the study of structure and conformation of peptides and proteins.


Subject(s)
Amino Acids/chemistry , Nitrogen Oxides/chemistry , Amino Acid Sequence , Electron Spin Resonance Spectroscopy/methods , Molecular Conformation , Protein Conformation , Spin Labels , Temperature
3.
Chem Commun (Camb) ; (6): 622-4, 2007 Feb 14.
Article in English | MEDLINE | ID: mdl-17264911

ABSTRACT

The spontaneous activation of a nonaromatic enediynyl azide under ambient conditions has been demonstrated. The aromatic enediyne followed the expected cycloaddition with the alkene in the neighbouring arm to form a stable bridged bicyclic enediyne.

4.
Stud Health Technol Inform ; 103: 159-79, 2004.
Article in English | MEDLINE | ID: mdl-15747918

ABSTRACT

This document has been prepared as a set of workshop material, which will be presented in the International Congress on Medical and Care Compunetics in June 2004 in Den Hague, The Netherlands. The workshop is divided into two parts and deals with the fundamentals of the bioavailability and bioequivalence studies. First part of the workshop deals with the pharmacokinetic principles, and the second part discusses the statistical approaches and the data analysis using the Statistical Analysis Software (SAS).


Subject(s)
Clinical Trials as Topic/statistics & numerical data , Clinical Trials as Topic/standards , Pharmacokinetics , Absorption/physiology , Biological Availability , Clinical Trials as Topic/legislation & jurisprudence , Delayed-Action Preparations , Drug Administration Routes , Drug Approval/legislation & jurisprudence , Drug Approval/methods , Drug Evaluation, Preclinical/standards , Drug Evaluation, Preclinical/statistics & numerical data , Humans , Metabolic Clearance Rate/physiology , Therapeutic Equivalency , United States , United States Food and Drug Administration
SELECTION OF CITATIONS
SEARCH DETAIL
...